OWC Pharmaceutical Research Corp (OWCP)

[PhenixBleu]

Hundreds of shareholders past and present are fully aware of the previous runs and the reason for those runs.

Last year the run occurred when we learned there would be no R/S, and that news was followed by a Notice of Allowance of the patent for skin conditions such as Psoriasis.

Unfortunately, the company didn't utter a word in support, stopped filing and left us totally in the dark. That's why the price could not be sustained.

To be clear, this event will not be repeated simply because this is the one-year anniversary.

The only recent development is the bankruptcy filing. Why anyone would buy on such news before the 60-90 timeframe runs, and without any idea what the outcome will be, is beyond my comprehension.

Folks, OWCP ran from $0.003 through $0.154 per share in Dec., 2019. We may see a similar run due to recent developments in coming days.